Arctic Vison

ArcticVison is committed to becoming a leading ophthalmology company in China, focusing on the development of breakthrough ophthalmic drugs with high commercial value and investing in high-tech fields such as gene therapy and rare diseases to address unmet clinical treatment needs in ophthalmic diseases and lead the Chinese ophthalmology treatment market. They are led by an elite team of seasoned professionals in the ophthalmology industry, possessing extensive successful experience in the research, development, and commercialization of ophthalmic products both in China and internationally.